U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07864493) titled 'Recorded Parent/Caregiver Voice for Infants With Neonatal Opioid Withdrawal Syndrome' on Sept. 28.

Brief Summary: Neonatal opioid withdrawal syndrome (NOWS) can affect a newborn infant's ability to eat, sleep, and be consoled after exposure to opioids before birth. Standard care at the participating neonatal units uses the Eat, Sleep, Console (ESC) approach, which emphasizes supportive care and involvement of parents and caregivers.

VOICE-NAS is a two-centre feasibility study evaluating whether a recorded parent/caregiver voice can be safely and practically added to usual ESC-based care for infants with NOWS. Approximately 15 to 20 ...